| |
|
|
|
Cambridge Healthtech Institute, The Fairmont Hotel, San Francisco, California
June 23-24, 2004
The challenge for systems biology is to transform the pharmaceutical industry by providing a means for identifying pathways that are critical to disease, and discovering both on- and off-target effects of compounds. The concept of a linear drug discovery and development spectrum is being replaced by an iterative process, where knowledge gained on a systems level is applied at various points in a continuum. The dynamic nature of biology is not easily modeled. However, by combining disparate types of data that interpret changes in genes, proteins, metabolites on a cellular level, it will comprise a set of parameters that when used together can provide a definitive means of diagnosis and evaluating drugs that alter disease outcome. Using a computational approach, a pathway can be connected with a clinical endpoint and a small molecule drug. This will eventually create predictive medicine that will improve the process of drug development and increase the number of efficacious compounds.
|
|
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute |
|
|
Invited Speakers:
|
|
For more information, visit: http://www.beyondgenome.com/isb.asp
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
.
|
|
|
|
|
|
|
|
Registration:
|
|
For more information, visit: http://www.beyondgenome.com/isb.asp
|
|
|
E-mail:
|
|
chi@healthtech.com
|
|
|
|
|
|
|
|
|